Cargando…
Clinical use of abiraterone in the treatment of metastatic castration-resistant prostate cancer
Prostate cancer remains the most common type of cancer among men in the United States. Treatment for metastatic prostate cancer has improved significantly over the years with more and more agents improving overall survival. This review will address the pathophysiology of prostate cancer followed by...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128838/ https://www.ncbi.nlm.nih.gov/pubmed/25157341 http://dx.doi.org/10.2147/RRU.S29003 |